These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 16950579)

  • 41. Enhanced skin delivery of quercetin by microemulsion.
    Kitagawa S; Tanaka Y; Tanaka M; Endo K; Yoshii A
    J Pharm Pharmacol; 2009 Jul; 61(7):855-60. PubMed ID: 19589226
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Dermal and transdermal delivery of an anti-psoriatic agent via ethanolic liposomes.
    Dubey V; Mishra D; Dutta T; Nahar M; Saraf DK; Jain NK
    J Control Release; 2007 Nov; 123(2):148-54. PubMed ID: 17884226
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Microemulsions as vehicles for topical administration of voriconazole: formulation and in vitro evaluation.
    El-Hadidy GN; Ibrahim HK; Mohamed MI; El-Milligi MF
    Drug Dev Ind Pharm; 2012 Jan; 38(1):64-72. PubMed ID: 21696340
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Evaluation of in vivo efficacy of topical formulations containing soybean extract.
    Georgetti SR; Casagrande R; Verri WA; Lopez RF; Fonseca MJ
    Int J Pharm; 2008 Mar; 352(1-2):189-96. PubMed ID: 18079076
    [TBL] [Abstract][Full Text] [Related]  

  • 45. In-situ phase transition from microemulsion to liquid crystal with the potential of prolonged parenteral drug delivery.
    Ren X; Svirskis D; Alany RG; Zargar-Shoshtari S; Wu Z
    Int J Pharm; 2012 Jul; 431(1-2):130-7. PubMed ID: 22548845
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Development and bioavailability assessment of ramipril nanoemulsion formulation.
    Shafiq S; Shakeel F; Talegaonkar S; Ahmad FJ; Khar RK; Ali M
    Eur J Pharm Biopharm; 2007 May; 66(2):227-43. PubMed ID: 17127045
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Enhanced oral bioavailability of Coenzyme Q10 by self-emulsifying drug delivery systems.
    Balakrishnan P; Lee BJ; Oh DH; Kim JO; Lee YI; Kim DD; Jee JP; Lee YB; Woo JS; Yong CS; Choi HG
    Int J Pharm; 2009 Jun; 374(1-2):66-72. PubMed ID: 19446761
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Oil-in-water lecithin-based microemulsions as a potential delivery system for amphotericin B.
    Pestana KC; Formariz TP; Franzini CM; Sarmento VH; Chiavacci LA; Scarpa MV; Egito ES; Oliveira AG
    Colloids Surf B Biointerfaces; 2008 Oct; 66(2):253-9. PubMed ID: 18676122
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Controlled poorly soluble drug release from solid self-microemulsifying formulations with high viscosity hydroxypropylmethylcellulose.
    Yi T; Wan J; Xu H; Yang X
    Eur J Pharm Sci; 2008 Aug; 34(4-5):274-80. PubMed ID: 18541418
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cyproterone acetate in topical delivery system.
    Lascu Z; Plakogiannis FM
    J Cosmet Sci; 2002; 53(5):299-301. PubMed ID: 12391999
    [No Abstract]   [Full Text] [Related]  

  • 51. Investigation of a nanoemulsion as vehicle for transdermal delivery of amlodipine.
    Kumar D; Aqil M; Rizwan M; Sultana Y; Ali M
    Pharmazie; 2009 Feb; 64(2):80-5. PubMed ID: 19320278
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Analysis of Tween based microemulsion in the presence of TB drug rifampicin.
    Mehta SK; Kaur G; Bhasin KK
    Colloids Surf B Biointerfaces; 2007 Oct; 60(1):95-104. PubMed ID: 17646089
    [TBL] [Abstract][Full Text] [Related]  

  • 53. In vitro skin permeation of sunscreen agents from O/W emulsions.
    Montenegro L; Carbone C; Paolino D; Drago R; Stancampiano AH; Puglisi G
    Int J Cosmet Sci; 2008 Feb; 30(1):57-65. PubMed ID: 18377631
    [TBL] [Abstract][Full Text] [Related]  

  • 54. NMR characterisation and transdermal drug delivery potential of microemulsion systems.
    Kreilgaard M; Pedersen EJ; Jaroszewski JW
    J Control Release; 2000 Dec; 69(3):421-33. PubMed ID: 11102682
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Influence of ethanol on the solubility, ionization and permeation characteristics of ibuprofen in silicone and human skin.
    Watkinson RM; Herkenne C; Guy RH; Hadgraft J; Oliveira G; Lane ME
    Skin Pharmacol Physiol; 2009; 22(1):15-21. PubMed ID: 19088498
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Enhancement of transdermal delivery of progesterone using medium-chain mono and diglycerides as skin penetration enhancers.
    Lopes LB; Murphy N; Nornoo A
    Pharm Dev Technol; 2009; 14(5):524-9. PubMed ID: 19552564
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Application of microemulsions in dermal and transdermal drug delivery.
    Santos P; Watkinson AC; Hadgraft J; Lane ME
    Skin Pharmacol Physiol; 2008; 21(5):246-59. PubMed ID: 18562799
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The influence of selected steroid hormones on the physicochemical behaviour of DPPC liposomes.
    Biruss B; Dietl R; Valenta C
    Chem Phys Lipids; 2007 Aug; 148(2):84-90. PubMed ID: 17555734
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Ophthalmic delivery of Cyclosporine A from Brij-97 microemulsion and surfactant-laden p-HEMA hydrogels.
    Kapoor Y; Chauhan A
    Int J Pharm; 2008 Sep; 361(1-2):222-9. PubMed ID: 18577433
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Self-nanoemulsifying drug delivery systems (SNEDDS) for oral delivery of protein drugs: I. Formulation development.
    Rao SV; Shao J
    Int J Pharm; 2008 Oct; 362(1-2):2-9. PubMed ID: 18650038
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.